This study was conducted to detect and analyse the presence of extended-spectrum b-lactamase (ESBL)-producing Klebsiella pneumoniae associated with a nosocomial outbreak at a Croatian hospital. During 2007, 162 K. pneumoniae isolates with reduced susceptibility to third-generation cephalosporins were collected from various hospital units and patient specimens. Most of the strains were isolated from urine (61 %), followed by blood cultures (13 %), wound swabs (13 %), tracheal aspirates (5 %), intra-abdominal abscess aspirates (4 %), intravascular catheters (3 %) and cerebrospinal fluid (1 %). Medical wards were the most important source of the isolates (46 %); 21 % of the isolates originated from surgical intensive-care units. All patients had infections acquired during their stay in hospital. No community-acquired infections were reported. Sixty of these isolates were chosen for further analysis. A double-disc synergy test (DDST) was used to detect ESBLs. MICs were determined by the broth microdilution method according to CLSI guidelines. The transferability of ceftazidime resistance was tested by conjugation (broth mating method). PCR was used to detect alleles encoding ESBL enzymes. Plasmids encoding ESBLs were extracted with the Macherey Nagel Mini kit according to the manufacturer's recommendations. The genotypes of the strains were compared by analysis of banding patterns generated by PFGE of XbaI-digested genomic DNA. ESBLs were found by DDST in all isolates. All strains were resistant to cefuroxime, ceftazidime, cefotaxime, ceftriaxone, aztreonam, piperacillin/tazobactam and ciprofloxacin. There was variable susceptibility/resistance to cefepime and gentamicin. No resistance to ceftazidime/clavulanate and carbapenems was observed. Only six strains transferred resistance to an Escherichia coli recipient strain, with low frequency. All isolates yielded an amplicon of 545 bp with consensus MA primers. Multiplex PCR was positive for group 1 CTX-M b-lactamases. Sequencing of selected amplicons revealed the presence of bla , with coding regions containing identical nucleotide sequences. Similarly to isolates from India, our isolates contained the ISEcpI insertion sequence located upstream of the bla CTX-M-15 gene, which has recently been demonstrated to mobilize 39-adjacent genes to transfer between DNA replicons. The isolates contained a large plasmid of approximately 150 kb. The isolates were assigned to five clusters (.85 % similarity), which contained subclusters. The results of this work provided insights into the molecular epidemiology of the spread of ESBLs in K. pneumoniae involved in an outbreak at a Croatian hospital. The hospital antibiotic policy resulted in ceftriaxone being the most heavily prescribed third-generation cephalosporin, which might be expected to select for cefotaximases such as CTX-M-15.
INTRODUCTION
Since plasmid-mediated extended-spectrum b-lactamases (ESBLs) were first detected in a Klebsiella oxytoca isolate in Germany in 1983 (Kliebe et al., 1985) , they have been reported increasingly worldwide. Production of ESBLs is the major mechanism of resistance to oxymino-cephalosporins and aztreonam in Gram-negative bacteria (Bradford, 2001; Jacoby & Munoz-Price, 2005) . ESBLs are predominantly derivatives of plasmid-mediated TEM or SHV b-lactamases, and arise through mutations that alter the configuration of the active site, thereby expanding the hydrolytic spectrum of the enzyme (Jacoby & Munoz-Price, 2005) . The CTX-M family of b-lactamases includes evolutionarily related ESBLs with a much higher level of activity against cefotaxime than against ceftazidime, and their similarity to some species-specific b-lactamases, such as those of Klebsiella oxytoca and Citrobacter diversus, has been known for some time (Pitout et al., 2005; Bonnet, 2004) . The recent finding of 99 % sequence similarity between the CTX-M-2 enzyme and the b-lactamase of Kluyvera ascorbata has indicated the origins of at least a fraction of the CTM variants (Baraniak et al., 2002) . In contrast to TEM and SHV ESBLs, which rely on point mutations in the bla TEM and bla SHV genes to expand their substrate profiles, CTX-M ESBLs have an intrinsic extended-spectrum profile. Whereas only four enzymes of this family (CTX-M-1, MEN-1, CTX-M-2 and Toho-1) were described between 1990 and 1995, the list has increased rapidly in recent years (Baraniak et al., 2002) . In some countries, CTX-M b-lactamases are the most prevalent types of ESBL, for instance in Switzerland (Lartigue et al., 2007) , Russia (Edelstein et al., 2003) , Greece (Pournaras et al., 2004) , Spain (Cantó n et al., 2002) , Japan (Yamasaki et al., 2003) , Taiwan (Yu et al., 2002) , China (Chanawong et al., 2002) and Argentina (Quinteros et al., 2003) .
Since the first isolation of ESBL-producing Klebsiella pneumoniae in Croatia (Bedenic & Zagar, 1998) , a growing variety of ESBL enzymes have been detected from members of the Enterobacteriaceae (Bedenic et al., 2001 (Bedenic et al., , 2005 . In Croatia, the first isolates found to produce CTX-M blactamases were Escherichia coli from the University Hospital in Split (Tonkic et al., 2007) . Very soon after the first report, CTX-M-producing E. coli were reported from other centres in Croatia (Literacka et al., 2009 ).
Recently, a significant increase in the prevalence of ESBLproducing K. pneumoniae was observed in the hospital in Pula, Croatia. The strains were associated with a hospital outbreak. The majority of strains showed higher levels of resistance to cefotaxime compared with ceftazidime, consistent with the production of CTX-M b-lactamases. The aim of this study was an epidemiological description of an outbreak of infections caused by ESBL-positive K. pneumoniae within the hospital with molecular characterization. We aimed to study the evolution of an outbreak associated with ESBL-producing klebsiellae in a healthcare institution.
METHODS
Bacterial isolates. During 2007, 162 K. pneumoniae isolates with reduced susceptibility to third-generation cephalosporins were collected from various hospital units and patient specimens in the General Hospital in Pula, Croatia. This represents 60 % (162/270) of the total number of K. pneumoniae isolates. The General Hospital at Pula is a 506-bed tertiary hospital and serves a population of 214 000 people. The mean age of the patients was 64.5 years (range 16-95). Most of the isolates were from urine (61 %), followed by blood cultures (13 %), wound swabs (13 %), tracheal aspirates (5 %), intraabdominal abscess aspirates (4 %), intravascular catheters (3 %) and cerebrospinal fluid (1 %) (Table 1) . Medical wards were the most important source of the isolates (46 %); 21 % of the isolates originated from surgical intensive-care units (Table 1 ). All patients had infections acquired during their hospital stay. The type of hospital infection was defined in accordance with Centers for Disease Control and Prevention criteria. No community-acquired infections were reported.
The strains were identified by conventional biochemical testing. ESBLs are routinely detected in the hospital laboratory by a doubledisc synergy test (DDST) performed on all K. pneumoniae isolates with reduced inhibition zones around ceftazidime and cefotaxime discs. Production of ESBLs was confirmed by E-test (AB Biodisk) and by the Vitek automated system (bioMérieux).
Sixty of the isolates were chosen for further analysis (Table 1 ). The isolate selection criterion was the availability of the strains for further analysis. Only 60 isolates had been inoculated in deep agar cultures to be preserved for future studies. Laboratory staff do not routinely keep all isolates, and the isolates that appeared at the beginning of the outbreak were not kept because the laboratory staff were not yet aware of the outbreak.
Antibiotic consumption. Consumption of antibiotics was measured in DDD (defined daily dosis).
Detection of ESBL by DDST. ESBL production was determined by DDST and confirmed by a reduction of at least threefold in the ceftazidime MIC by clavulanate (Jarlier et al., 1988) .
Antibiotic susceptibility testing. Susceptibilities to a wide range of antibiotics were determined by disc-diffusion and broth microdilution methods. MICs were determined in microtitre plates and Mueller-Hinton broth according to CLSI guidelines (CLSI, 2007) . E. coli ATCC 25922 was used for quality control.
A phenotype consistent with production of a CTX-M-type blactamase was defined by a cefotaxime MIC ¢8-fold higher than the ceftazidime MIC, with the MICs of both agents being reduced significantly (¢8-fold) in the presence of 4 mg clavulanic acid l
(CLSI, 2007).
Transfer of resistance determinants. K. pneumoniae isolates were investigated for the transferability of their resistance determinants. Conjugation experiments were set up employing E. coli A15R 2 strain, which is free of plasmids and resistant to rifampicin (Elwell & Falkow, 1986) . Transconjugants were selected on combined plates containing cefotaxime (1 mg l
21
) and rifampicin (256 mg l 21 ). The frequency of conjugation was expressed relative to the number of donor cells.
Characterization of ESBLs. The presence of bla ESBL genes was determined by PCR using primers targeting bla TEM , bla SHV , bla CTX-M and bla PER genes and conditions described previously (Nüesch-Inderbinen et al., 1996; Arlet et al., 1995; Woodford et al., 2004) . Bacterial DNA was extracted by the boiling method. Primers used in this study were MN-1 and MN-2 (Nüesch-Inderbinen et al., 1996) for detection of SHV b-lactamases, OT-3 and OT-4 (Arlet et al., 1995) for detection of TEM b-lactamases, MA-1 and MA-2 (Woodford et al., 2004) for detection of CTX-M b-lactamases and PER-1F and PER-1R (Pagani et al., 2004) for detection of PER b-lactamases (Table 2 ). bla OXA-1 genes were amplified with primers OXA-1F and OXA-1R. Strains were further tested by multiplex PCR with primers specific for CTX-M groups 1, 2, 8, 9 and 25 . Since the above primers do not amplify the whole coding sequence of the bla CTX-M gene, we used additional primers to distinguish between CTX-M-15 and CTX-M-28. The sequences of these primers were kindly provided by Professor L. Martinez (Santander, Spain) (personal communication). Primers IS26F and IS26R were used to amplify a 400 bp fragment spanning the link between the IS26 insertion sequence and the bla CTX-M gene in CTX-M-producing isolates (Woodford et al., 2004) . Primers ISEcp1L1 and ALA-5 were applied to amplify the ISEcpI insertion sequence (Literacka et al., 2009) .
In order to determine the genetic context of bla CTX-M genes, PCR mapping was performed using primers for IS26 and ISEcpI combined with forward and reverse primers for bla CTX-M genes (Saladin et al., 2002) . PCR products were visualized by agarose gel electrophoresis after staining with ethidium bromide. Amplicons from selected , 1996) .
Detection of quinolone resistance determinants. Plasmid-borne quinolone resistance genes qnrA, qnrB and qnrS were detected by PCR as described previously (Robicsek et al., 2006a, b) .
Characterization of plasmids encoding ESBLs. Plasmids were extracted with the Macherey Nagel Mini kit according to the manufacturer's instructions from 20 representative strains. The sizes of plasmids were estimated from a standard curve of the logarithm of molecular size of four plasmids of 148, 64, 36 and 7 kb, respectively, from E. coli NTCC 50192 against the logarithm of relative mobility. Plasmid extractions were subjected to PCR with primers specific for ESBLs.
Molecular typing by PFGE of bacterial DNA. PFGE genotyping of XbaI-digested genomic DNA was performed with a CHEF-DRIII system (Bio-Rad); the images were processed using the GelCompar software and a dendrogram was computed after band intensity correlation using global alignment with 2 % optimization and UPGMA (unweighted pair-group method using arithmetical averages) clustering. The isolates were considered to be clonally related if they showed more than 80 % similarity (or differed by fewer than three bands) in their PFGE patterns (Kaufman, 1998; Tenover et al., 1995) .
RESULTS AND DISCUSSION

Antibiotic consumption
Ceftriaxone was the most prescribed extended-spectrum cephalosporin during 2004-2007 in the hospital, as shown in (Table 3) .
Detection of ESBLs
All strains resistant to third-generation cephalosporins were found by DDST to produce ESBLs. (Table 4 ). The most potent antibiotics were ceftazidime combined with clavulanate and carbapenems, with MIC 90 of 0.25 and 0.5 mg l 21 , respectively (Table 4) .
Conjugation
Only ten strains transferred resistance to the E. coli recipient strain, with low frequency. Resistance to tetracycline was cotransferred to the recipient strain with cefotaxime resistance from ten strains and sulfamethoxazole resistance from nine strains. Resistance to cefoxitin and ciprofloxacin was not transferable.
Characterization of b-lactamases
The b-lactamase contents of the isolates are shown in Table 1 . All isolates yielded an amplicon of 545 bp with consensus MA primers. Donor strains were also positive for SHV blactamases. No PCR products were obtained in transconjugants with primers specific for bla SHV . Transconjugant strains possessed only the CTX-M b-lactamases of group 1. Multiplex PCR was positive for group 1 of CTX-M blactamases. Sequencing of selected amplicons revealed the presence of bla CTX-M-15 , with coding regions containing identical nucleotide sequences. The DNA sequence of the PCR products exhibited 98 % similarity to bla CTX-M-15 from GenBank. The PCR Nhe test was negative for all SHV-PCR products, indicating the presence of the intrinsic SHV-1 blactamase of K. pneumoniae. The clinical isolates also possessed TEM-1 b-lactamase, which is not an ESBL, but the gene encoding this enzyme was not transferable to a recipient strain in the conjugation experiment. Sequencing of selected TEM amplicons revealed the presence of TEM-1 blactamase. PER-1 and OXA-1 b-lactamases were not found.
PCR mapping
The IS26 insertion sequence was not found. ISEcpI was found upstream of the bla CTX-M-15 gene.
Characterization of fluoroquinolone resistance determinants
PCRs with primers specific for qnrA, qnrB and qnrS genes were negative.
Characterization of plasmids encoding ESBLs
A large plasmid of approximately 150 kb was isolated from all 20 tested strains. The strains also possessed one or two smaller plasmids of less than 36 kb. Five different plasmid profiles were observed. In a future study, we will digest the plasmids with EcoRI restriction endonuclease to determine whether they are related. Plasmid extractions were positive for CTX-M and TEM b-lactamases but negative for SHV blactamases.
Genotyping of the isolates
The isolates were assigned to five clusters (.85 % similarity) which contained subclusters, as shown in Table 1 and Fig. 1 . The subclusters differed from each other in two to three bands, which is consistent with a single genetic event (point mutation or insertion or deletion of DNA). Cluster 2 was predominant among the isolates and contained 34 isolates. Two strains were sporadic and showed distinct PFGE fingerprints (differed in .50 % of the well-resolved fragments). There were several breakouts caused by genetically identical strains. The results of this work provide insights into the molecular epidemiology of the spread of ESBLs in K. pneumoniae involved in an outbreak at a Croatian hospital. A significant increase in the prevalence of ESBL-producing K. pneumoniae in 2007 (60 %) indicated a hospital outbreak. Our study found CTX-M-15 b-lactamase to be the most prevalent among isolates of K. pneumoniae. This type of CTX-M b-lactamase is the most prevalent around the world, and was previously reported in nearby countries such as Hungary (Livermore et al., 2007) , Austria (Eisner et al., 2006) , Slovenia (Meško Meglič et al., 2009) and Italy (Mugnaioli et al., 2006) . It was first described in New Delhi, India, in 1999 (Karim et al., 2001) . CTX-M-15 is also predominant in other European countries such as Switzerland (Lartigue et al., 2007) , Bulgaria (Markovska et al., 2004) , France (Lavigne et al., 2006) and Spain (Oteo et al., 2009) . Previous studies also found CTX-M-15 among hospital isolates of E. coli from Croatia (Literacka et al., 2009) . CTX-M-15 differs from CTX-M-3 b-lactamase by a single amino acid change (Asp-240AGly).
In this study, we tested isolates for TEM, SHV, CTX-M and PER blactamases. Whereas these genes were found in all isolates, other rare types of ESBLs such as WEB or IBC cannot be excluded without further testing, but were beyond the scope of this study.
Clustering of K. pneumoniae isolates sustains the hypothesis of either patient-to-patient transmission or common source acquisition (e.g. contaminated equipment for mechanical ventilation). It is interesting that genetically identical organisms appeared in different time periods, in Associated aminoglycoside and fluoroquinolone resistance is frequent in ESBL-producing bacteria. Some of the strains were resistant to cefoxitin, but resistance was not transferable to an E. coli recipient, indicating a chromosomal origin of the resistance gene. Concerning non-blactam susceptibilities of CTX-M producers, all strains were resistant to ciprofloxacin. High rates of resistance to ciprofloxacin in CTX-M producers have also been reported from Austria (Eisner et al., 2006) , Canada (Pitout et al., 2005) , Italy (Mugnaioli et al., 2006) and Hungary (Damjanova et al., 2008) . Similar to the situation in Croatia, ciprofoxacin-resistant K. pneumoniae isolates from Hungary were associated with epidemic clones (Damjanova et al., 2008) . PCRs with primers specific for qnr genes were negative. However, the fluoroquinolone resistance in our strains was probably due to mutations in genes coding for chromosomally encoded type II topoisomerases, efflux pumps or porin-related proteins; determination of the exact mechanism of resistance was beyond the scope of this study. Since fluoroquinolones are often used to treat urinary tract infections, and the urinary tract was the most important source of CTX-M-15-producing isolates, it is possible that fluoroquinolones exerted selection pressure that favoured survival of isolates that possessed quinolone resistance determinants. Coresistance to non-b-lactam antibiotics is also frequent, either by cotransfer of the resistance determinants in the same genetic elements (such as aminoglycoside resistance) or simply by coselection of the two resistance mechanisms, as occurs with fluoroquinolones.
Since plasmids encoding ESBLs also contain resistance genes for aminoglycosides, it is possible that consumption of these antibiotics could exert selection pressure that favours the spread of plasmids with ESBL genes. In this study, only 10 of 60 strains possessed conjugative plasmids.
Other mating methods should be tested, such as the filter mating method, to determine whether they would yield more transconjugants, but this was not feasible in our laboratory. The hospital antibiotic policy results in ceftriaxone being the most heavily prescribed thirdgeneration cephalosporin, which might be expected to select for cefotaximases such as CTX-M-15. Substitution of piperacillin/tazobactam for extended-spectrum cephalosporins has been shown to decrease the prevalence of ESBLs in K. pneumoniae and E. coli (Lee et al., 2007) . There are no published reports on the correlation between antibiotic usage and the increased prevalence of CTX-M blactamases, but there are bibliographic data that show that changes in antibiotic policy have resulted in decreases in ESBL production in E. coli and K. pneumoniae (Lee et al., 2007) .
Several reports have suggested that the ability of the ISEcpI element to mobilize and promote expression of CTX-M-15 is a significant factor in rapid spread of the bla CTX-M-15 gene (Markovska et al., 2004) , and this could be the mechanism that underlies the spread of the CTX-M-15 enzyme in Croatia. However, the spread of bla CTX-M genes is largely due to the overall genetic background of the strain and plasmid.
PFGE analysis showed that the outbreak of CTX-Mproducing K. pneumoniae was caused by isolates that were highly related, in contrast to several studies that have found the spread of single clones (Eckert et al., 2004; Oteo et al., 2006) .
Regular evaluation of isolate characteristics and monitoring the spread of the more virulent isolates within inpatient population are essential for timely identification and efficient management of nosocomial outbreaks. All patients were treated with meropenem. Heightened infection control measures and discouraged use of third-generation cephalosporin antibiotics led to effective control of the outbreak, which had ceased by the end of 2007.
The emergence of CTX-M enzymes in Croatia and elsewhere highlights the importance of using either both ceftazidime and cefotaxime or cefpodoxime to detect possible ESBL production prior to performing cephalosporin-clavulanate synergy tests for confirmation (Winstanley et al., 2004) .
Outbreaks caused by CTX-M-producing organisms are still very rare and have been reported only sporadically (Bradford et al., 1998; Palucha et al., 1999; Kiratisin et al., 2007; Mena et al., 2006) . The rapid spread of CTX-M-15 blactamase between different wards was attributable to clonal dissemination of related strains and horizontal transfer of multiresistant plasmids carrying bla CTX-M-15 genes between isolates. CTX-M-15 producers constantly evolve in the hospital, acquiring other mechanisms of resistance to b-lactams, which is probably driven by the high-level use of newer b-lactam antibiotics.
Finally, the spread of CTX-M-producing members of the Enterobacteriaceae in Croatia in a manner similar to that observed in neighbouring countries may indicate difficulties in controlling this emerging resistance determinant irrespective of the antibiotic policy. This demonstrates the need to monitor both hospitalized and general practice patients for the further emergence of transferable resistance to extended-spectrum cephalosporins. Continuous surveillance in tracking CTX-M-producing K. pneumoniae in the hospital is necessary to prevent their influx into the community.
